Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy.
Takeda K, Yamaguchi N, Akiba H, Kojima Y, Hayakawa Y, Tanner JE, Sayers TJ, Seki N, Okumura K, Yagita H, Smyth MJ.
Takeda K, et al. Among authors: okumura k.
J Exp Med. 2004 Feb 16;199(4):437-48. doi: 10.1084/jem.20031457. Epub 2004 Feb 9.
J Exp Med. 2004.
PMID: 14769851
Free PMC article.